Oral Herbal Combination Formulation and Hair Growth in Women
Hair Loss, Hair Thinning
About this trial
This is an interventional other trial for Hair Loss
Eligibility Criteria
Inclusion Criteria:
- Age 18 and above
- Subject must be able to read and comprehend study procedures and consent forms.
- Women with self-perceived hair loss as confirmed by the investigator.
- Willing to maintain the same hairstyle, hair color, hair length and hair regimen throughout the study period. Subjects with color-treated hair will have the color treatment performed at the same time interval prior to each visit (if the color treatment was done 1 week prior to Visit 1, it should be repeated 1 week prior to Visit 2).
- Willing to keep diet and exercise routine consistent throughout study
Exclusion Criteria:
- Subjects should be generally healthy and have no smoking history in the past one year.
- Subjects must have no history of diabetes, metabolic syndrome, HIV, immune deficiency, autoimmune disease known cardiovascular disease, malignancy, kidney disease, or chronic steroid use.
- Women who are pregnant, planning to become pregnant or breastfeeding
- Those who are unable to discontinue medicated shampoos or topical scalp medications for two weeks prior to and during the study.
- Those who are unable to discontinue supplements containing Eclipta alba, Emblica officinalis, Centella asiatica and Hibiscus sabdariffa for one month prior to starting the study
- Those who have a known allergy to Eclipta alba, Emblica officinalis, Centella asiatica or Hibiscus sabdariffa
- Use of hair regrowth products in the previous 6 months
- Using or planned use of non-breathable wigs
- Those with a history of hair transplantation procedure
- Presence of other dermatological disorders causing alopecia
- Chemotherapy, radiation therapy or laser therapy (of scalp) in the last 6 months
- Light therapy in the past 3 months
- Participants using hormonal birth control unless on a stable / unchanged regimen for at least 3 months.
- Systemic treatment during the last 3 months before study inclusion that could interfere with the study medications (ie, minoxidil, corticosteroids, Aminexil, topical estrogens, ketoconazole, beta blocker, cimetidine, diazoxide, isotretinoin or vitamin A intake >10,000 IU/d)
- Use of ocular prostaglandins for less than 4 months before first study visit
- Those that are prisoners or cognitively impaired
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Herbal Combination Group
Placebo Group
Tablets of the herbal formulation will be supplied from Banyan Botanicals (https://www.banyanbotanicals.com/healthy-hair-tablets-10) Each 500 mg tablet contains a proprietary blend of: Eclipta alba, Emblica officinalis, Centella asiatica and Hibiscus sabdariffa Dose: subjects in this group will take 2 herbal formulation tablets twice per day for a total of 4 tablets per day
Supplement appearing similar to the herbal combination formulation. Each placebo tablet will contain microcrystalline cellulose, dicalcium phosphate, PVPK30, sodium starch glycolate, magnesium stearate, OpaDry orange coating. Dose: subjects in this group will take 2 placebo tablets twice per day for a total of 4 tablets per day